Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.

Advances in experimental medicine and biology - 1 Jan 2000

Magdolen V, Arroyo de Prada N, Sperl S, Muehlenweg B, Luther T, Wilhelm O G, Magdolen U, Graeff H, Reuning U, Schmitt M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amiloride
Share to Guanidines
Share to Plasminogen Activator Inhibitor 1
Share to Receptors, Urokinase Plasminogen Activator

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Serine Proteinase Inhibitors

Share to Serpins

Share to Thiophenes

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 10849761
DOI: 10.1007/0-306-46826-3_36

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator.PMID 10849761Read ↗

Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.Semantic proximity Read ↗

Tissue-type plasminogen activator: mutants, variants, and adjunctive treatment.Semantic proximity Read ↗

Characterization of a small molecule PAI-1 inhibitor, ZK4044.Semantic proximity Read ↗

Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidateSemantic proximity Read ↗

[New types of plasminogen activators].Semantic proximity Read ↗

Molecular biologic modification of plasminogen activators. An artful science.Semantic proximity Read ↗

Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.Semantic proximity Read ↗

Newer thrombolytic agents.Semantic proximity Read ↗

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.Semantic proximity Read ↗

An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.Semantic proximity Read ↗

Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation.Semantic proximity Read ↗

Properties of a novel plasminogen activator (BM 06.022) produced in Escherichia coli.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.